HMGB3 and colorectal carcinoma: As shown in Figures 4A, B and Supplementary Figure 2, the anti-tumor effects of 5-FU in CRC cells were enhanced by the miR-200b-3p agomir; however, these changes were notably reversed by HMGB3 overexpression.